GLUTAMATE RECEPTOR ANTAGONISTS AS NEUROPROTECTIVES

摘要

The invention relates to the use of an inhibiting agent of t-PA of mediated activation of the glutamate receptor, preferably of the NMDA type, as neuroprotectives.